Renate Pichler, Johannes Stäblein, Andrea Mari, Luca Afferi, David D'Andrea, Gautier Marcq, Francesco Del Giudice, Francesco Soria, Jorge Caño-Velasco, José Daniel Subiela, Andrea Gallioli, Karl H Tully, Keiichiro Mori, Achim Herms, Benjamin Pradere, Marco Moschini, Laura S Mertens, Martin Thurnher
In non-muscle invasive bladder cancer, Bacillus Calmette-Guérin (BCG) responders benefit from strong Th1-type inflammatory and T cell responses mediating tumor rejection. However, the corresponding lack of anti-inflammatory Th2-type immunity impairs tissue repair in the bladder wall and facilitates the development of cystitis, causing urinary pain, urgency, incontinence, and frequency. Mechanistically, the leakage of the glycosaminoglycan (GAG) layer enables an influx of potassium ions, bacteria, and urine solutes towards the underlying bladder tissue, promoting chronic inflammation...
March 31, 2024: Journal of Clinical Medicine